Daesung Microbiological Labs Dividends and Buybacks
Dividend criteria checks 1/6
Daesung Microbiological Labs is a dividend paying company with a current yield of 0.89%.
Key information
0.9%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Daesung Microbiological Labs (KOSDAQ:036480) Is Carrying A Fair Bit Of Debt
Aug 06
Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?
May 08Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Mar 15We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability
Feb 17
Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?
Jan 21Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years
Dec 31Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?
Dec 10Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A036480 has been paying a dividend for less than 10 years.
Growing Dividend: A036480 has only been paying a dividend for 3 years, and since then payments have not increased.
Dividend Yield vs Market
| Daesung Microbiological Labs Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A036480) | 0.9% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Biotechs) | 0.6% |
| Analyst forecast (A036480) (up to 3 years) | n/a |
Notable Dividend: A036480's dividend (0.89%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.21%).
High Dividend: A036480's dividend (0.89%) is low compared to the top 25% of dividend payers in the KR market (3.98%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A036480's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (21.8%), A036480's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/02 13:11 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daesung Microbiological Labs. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.